INCIDENCE AND MEDICAL TREATMENT OF OCTREOTIDE INDUCED GALLSTONES IN SUBJECTS WITH RESISTANT ACROMEGALY : A PROSPECTIVE STUDY

Octreotide was used to treat eight patients with acromegaly. Octreotide dose was increased to 1500 mcg subcutaneously per day during the first year, and was then reduced to 600 mcg per day for three years.